ClinicalTrials.Veeva

Menu

Role of markErs in the progreSsion of dIabeteS in Obese paTIeNts (RESISTIN)

U

University of Pavia

Status

Completed

Conditions

Obese Patients

Treatments

Other: Progression of diabetes

Study type

Observational

Funder types

Other

Identifiers

NCT02934737
20160004418

Details and patient eligibility

About

Obese patients will be enrolled from 2006 to 2014. The progression of diabetes mellitus will be observed (if any). Anthropometric and biochemical parameters will be evaluated.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Obesity (body mass index >/= 30 Kg/m2
  • Normal blood glucose (glycemia < 100 mg/dl)

Exclusion criteria

  • No exclusion criteria

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems